Picture of Maven Income and Growth VCT 4 logo

MAV4 Maven Income and Growth VCT 4 News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapNeutral

REG - MavIncGroVCT4 - Half-year Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240918:nRSR7038Ea&default-theme=true

RNS Number : 7038E  Maven Income & Growth VCT 4 PLC  18 September 2024

Maven Income and Growth VCT 4 PLC

 

Interim Results for the Six Months Ended 30 June 2024

 

Highlights

 

•    NAV total return at 30 June 2024 of 155.04p per share

 

•    NAV at 30 June 2024 of 62.19p per share

 

•    Interim dividend of 2.00p per share

 

•    Offer for Subscription closed, raising £5.8 million

 

•    Two new private companies added to the portfolio, with a further two
investments completed post period end

 

•    Exit achieved from GradTouch, generating a total return of 1.5x cost

 

•    Final exit achieved from Quorum Cyber, generating a total return of
8.2x cost

 

•    Post period end partial exit achieved from MirrorWeb, generating a
total return of 4.7x cost, including an ongoing equity stake

 

•    Post period end partial exit achieved from Novatus Global,
generating a total return of 4.7x cost, including an ongoing equity stake

 

•    Post period end exit achieved from CB Technology, generating a total
return of 2.9x cost

 

Interim Review

 

Overview

 

In the six months to 30 June 2024, your Company has made further positive
progress and it is pleasing to report an increase in NAV total return. Since
the year end, there has been a strong level of M&A activity across the
private company portfolio, which has resulted in the completion of five
profitable realisations, including several high value exits to strategic US
buyers. In June, the sale of the residual interest in Quorum Cyber completed,
generating a total return of 8.2x cost over the life of the investment and, in
August, the partial sale of MirrorWeb completed, generating a total return of
4.7x cost, with the partial exit from Novatus Global completing in early
September and generating a total return of 4.7x cost. With MirrorWeb and
Novatus, the exit considerations consisted of a combination of cash and a
continuing equity stake, which allows your Company to participate in the
future growth of these businesses with scope for a further return in the
future. In recognition of the exit activity and the commitment to make regular
tax free distributions, an increased interim dividend of 2.00p per share has
been declared for payment in October 2024.

 

In the year to date, your Company has completed five profitable private
company exits to UK and US buyers, helping to validate the Manager's
investment strategy and sector focus. Following a muted period for M&A
within the technology sector in 2023, the market has recovered strongly.
Notably, there has been a reemergence of US private equity buyers who are
attracted to UK speciality software companies that have a market leading
product and a clear path to scalable growth. A key part of their acquisition
rationale is to provide financial resource to help these businesses accelerate
growth plans and realise their full potential.

 

In early June, the final exit from cyber security specialist Quorum Cyber
completed with the sale of the residual holding. Your Company first invested
in Quorum in 2020, backing an experienced team that had established a leading
position in a high growth market. Following a period of rapid expansion, the
investment was partially realised through a sale to UK private equity house
Livingbridge in December 2021, generating an initial return of 6.5x cost over
an 18 month holding period. This transaction provided Quorum with additional
capital to support the next phase of its strategic development and, in
recognition of the growth prospects, the Maven VCTs retained a minority equity
interest in the business in order to participate in its future success. In
June this year, a final exit from this investment was achieved through a sale
of the business to US private equity firm, Charlesbank Capital Partners,
taking the total proceeds to 8.2x cost over the life of the investment.

 

A further notable exit was the partial sale of digital archiving specialist
MirrorWeb, which completed in August 2024. Your Company first invested in
MirrorWeb in 2020, supporting an ambitious management team who had developed a
disruptive software platform with significant growth potential and a large
addressable market. Since investment, the business consistently delivered
strong revenue growth and established a leading position in the communications
surveillance market, with a focus on the financial services sector where the
platform supports regulatory requirements in relation to data archiving. In
2023, the business successfully expanded into the US, which led to an
unsolicited approach to acquire the business from a US private equity buyer.
Following this approach, a competitive exit process was initiated, with the
sale to US private equity acquirer MainSail completing in August. The exit
generated a total return of 4.7x cost, comprising of a cash consideration and
an ongoing equity stake that enables your Company to maintain an economic
interest in the business with the potential for a further return in the
future.

 

In early September 2024, the partial sale of regtech specialist Novatus Global
completed, achieving the highest value sale price to date from your Company's
unlisted technology portfolio. Following investment by your Company, Novatus
made rapid commercial progress, capitalising on the growth opportunities
within its core market, where its advisory services and software platform
helps financial institutions to prevent and resolve regulatory and compliance
issues. Over the past two years, the business achieved a 250% increase in
annual recurring revenue (ARR), driven by the development of its proprietary
transaction reporting software platform, which is gaining market traction and
a strong reputation. The business recently opened its first international
office in Australia to capture the significant opportunity in this region.
Novatus received an unsolicited acquisition approach from US private equity
firm Silversmith Capital Partners at a premium to carrying value, reflective
of the strategic value of the technology. The exit generated a total return of
4.7x cost, which includes cash and an ongoing equity element that enables your
Company to participate in the future growth of this business.

 

Specialist electronics manufacturer CB Technology was one of the more mature
holdings in the portfolio and, following a period of strong trading
performance, an exit process was initiated in 2023. An offer to acquire the
business was subsequently received from a private equity backed trade
acquirer, with the exit completing in early September 2024 and generating a
total return of 2.9x cost. In addition, in May 2024 your Company completed the
exit from graduate recruitment specialist GradTouch, with a sale to a UK
private equity house that generated a total return of 1.5x cost, inclusive of
a small deferred element.

 

Achieving profitable exits in order to maximise Shareholder returns and
distributions remains a key priority. However this has to be balanced against
selling a business too early before its value has been fully optimised. In
cases like Quorum, MirrorWeb and Novatus, where a business is performing
strongly and has the potential to become a large and valuable asset, the
Manager will seek to maintain an economic interest when structuring an exit.
This approach allows your Company to generate a healthy initial cash return
from a secondary transaction or partial sale, to help support the dividend
programme, whilst retaining an ongoing equity interest in the business, which
offers the potential for a further return in the future.

 

Your Company continues to make further progress in line with its long term
growth strategy, which is focused on constructing a large and diverse
portfolio of innovative companies that have the potential to grow rapidly and
ultimately become attractive to a wide range of acquirers. During the
reporting period, a total of £2.6 million was deployed through the addition
of two new private companies to the portfolio, alongside the provision of
follow-on funding to support the further development of 13 existing unlisted
holdings, as well as two small AIM transactions. The investment strategy
continues to focus on identifying entrepreneurial companies that operate in
disruptive or high growth markets, where there is an opportunity to achieve
scale over the medium term. Maven retains a strong preference for investing in
companies that operate in dynamic sectors such as cyber security, software,
niche manufacturing, data analytics, healthtech and training, where growth is
less sensitive to consumer or discretionary spending and the revenue model
tends to be recurring in nature, which provides good visibility on the growth
trajectory of each portfolio company. To ensure that the business plan can be
delivered, Maven also spends time assessing the calibre of management and
their track record, recognising that experienced and cohesive teams are
crucial to the success of early stage businesses.

 

In April 2024, your Company closed its most recent top-up Offer having raised
a total of £5.8 million for the 2023/24 and 2024/25 tax years. These funds
will enable your Company to progress its investment strategy which, over the
past four years, has provided growth capital to more than 40 private
companies, many of which are delivering strong growth and achieving a leading
position in their respective markets.

 

Dividend Policy

 

The Board and the Manager recognise the importance of tax free distributions
to Shareholders and will seek, as a guide, to pay an annual dividend that
represents 5% of the NAV per share at the immediately preceding year end. This
policy is under close and regular review by the Board and the Manager,
particularly in light of the current level of profitable exit activity.

 

Decisions on distributions take into consideration a number of factors,
including the realisation of capital gains, the adequacy of distributable
reserves, the availability of surplus revenue and the VCT qualifying level,
all of which are kept under close and regular review. As the portfolio
continues to expand and a greater proportion of holdings are invested in
younger companies with growth potential, the timing of distributions will be
more closely linked to realisation activity, whilst also reflecting the
Company's requirement to maintain its VCT qualifying level.

 

Interim Dividend

 

In respect of the year ending 31 December 2024, an increased interim dividend
of 2.00p per share will be paid on 18 October 2024 to Shareholders who are on
the register at 20 September 2024. Since the Company's launch, and after
receipt of this interim dividend, a total of 94.85p per share will have been
paid in tax free Shareholder distributions. It should be noted that the
payment of a dividend reduces the NAV of the Company by the total amount of
the distribution.

 

Dividend Investment Scheme (DIS)

 

Your Company operates a DIS, through which Shareholders can, at any time,
elect to have their dividend payments utilised to subscribe for new Ordinary
Shares issued by the Company under the standing authority requested from
Shareholders at Annual General Meetings. Shares issued under the DIS should
qualify for VCT tax relief applicable for the tax year in which they are
allotted, subject to an individual Shareholder's particular circumstances.

 

Shareholders can elect to participate in the DIS in respect of future
dividends by completing a DIS mandate form and returning it to the Registrar
(The City Partnership). In order for the DIS to apply to the 2024 interim
dividend, the mandate form must be received before 4 October 2024, this being
the relevant dividend election date. The mandate form, terms & conditions
and full details of the scheme (including tax considerations) are available
from the Company's webpages at: mavencp.com/migvct4. Election to participate
in the DIS can also be made through the Registrar's online investor hub at:
maven-cp.cityhub.uk.com/login.

 

If a Shareholder is in any doubt about the merits of participating in the DIS,
or their own tax status, they should seek advice from a suitably qualified
adviser.

 

Offer for Subscription

 

The most recent Offer for Subscription closed on 26 April 2024, with your
Company raising a total of £5.8 million for the 2023/24 and 2024/25 tax
years. All new shares in relation to this Offer have now been issued, with
four allotments for the 2023/24 tax year and one allotment for the 2024/25 tax
year.

 

This additional liquidity will facilitate the further expansion and
development of the portfolio in line with the investment strategy. The funds
raised will also allow your Company to maintain its share buy-back policy,
whilst also spreading costs over a wider asset base, with the objective of
maintaining a competitive ongoing charges ratio for the benefit of all
Shareholders.

 

As announced on 18 June 2024, the Directors have elected to launch a new Offer
for Subscription, which will run alongside Offers by the other Maven managed
VCTs. Full details will be included in the Prospectus, which is expected to be
published in Autumn 2024.

 

Portfolio Developments

 

It is encouraging to report on the progress that has been achieved across the
private equity portfolio, where most companies have continued to meet
operational and financial targets as part of their business plans. Many of the
earlier stage growth companies are now achieving scale and establishing strong
positions in their respective markets and, in recognition of the progress
achieved, the valuations of certain holdings have been uplifted.

 

Cyber security specialist CYSIAM continues to make positive progress, with
revenues increasing by more than 200% since your Company first invested. The
business is building a strong reputation as a leading provider of Managed
Detection and Response (MDR) security services for protection against,
detection of and response to cyber attacks. CYSIAM is a recognised expert in
its field and, as an accredited member of the National Cyber Security Centre's
Cyber Incident Response scheme, it can provide direct support to a range of
organisations when they become victims of cyber attacks. CYSIAM operates in a
dynamic, high growth market and the near term strategic objective remains to
further pivot the business towards a Software as a Service (SaaS) model, which
will result in an increased level of recurring revenue.

 

In 2021, your Company invested in Guru Systems, a supplier of hardware,
software and data analytics designed to improve the performance and cost
effectiveness of heat networks. Since investment, the business has gained
commercial traction in an emerging sector that has positive ESG credentials.
Heat networks are an important part of the government's decarbonisation
strategy and are increasingly required to be included as part of the design of
any new residential and commercial property developments. Given the strong
growth potential of this market, Guru is well placed to achieve scale over the
medium term.

 

Carbon reduction software specialist Manufacture 2030 has delivered impressive
revenue growth over the past year, with ARR increasing by over 75%. The
business provides a disruptive software solution that helps multinationals
achieve Scope 3 carbon reduction targets by measuring, managing and reducing
carbon emissions across their supply chain. The business is establishing a
leading position in a high growth market, where its proposition is aligned
with various carbon reduction initiatives including the United Nations
Sustainable Development Goals. Manufacture 2030 partners with a wide range of
blue chip clients, including Asda, Co-op, GSK, Toyota and Unilever, and has
received a number of awards as a technology pioneer within this evolving
sector. The near term objective is to expand its presence in North America,
which is viewed as a key growth market.

 

Automotive ecommerce software specialist Rockar continues to increase its
market share and is now a leading provider of a disruptive white label
solution for buying and selling new and used cars online. The business has
signed commercial agreements with various high profile automotive
manufacturers such as BMW, Jaguar Land Rover, Toyota Motor Group and Volvo UK,
with development work ongoing with several others. Rockar's new operating
platform, Evolution, is gaining traction amongst clients, with a number
already using or committed to migrating across to the new operating system.
The business continues to deliver strong revenue growth and remains focused on
building relationships with global automotive manufacturers, and the outlook
for the year ahead is encouraging.

 

Digital payments software provider QikServe has made further encouraging
commercial progress and is capitalising on the shift within the hospitality
sector towards mobile ordering and pay-at-table technology. The business
continues to expand its market presence in targeted sectors that include
restaurants, international coffee chains and transportation hubs. QikServe has
a growing estate, with more than 8,000 sites in over 40 countries and a
healthy pipeline of near term opportunities, particularly in the US.

 

Contract software specialist Summize continues to make positive commercial
progress, with ARR growing by almost 200% since the Maven VCTs first invested
in October 2022. The business has developed an AI-powered digital contracting
software solution that simplifies and streamlines the process for writing and
renewing contracts, helping to drive operational efficiencies for customers.
Since inception in 2018, Summize has secured numerous industry awards for its
innovation and entrepreneurialism. Having established a strong foothold in the
UK, the next phase of growth for the business is to expand into the US, where
a significant market opportunity has been identified.

 

As may be expected with a large portfolio, there are a small number of
investee companies that have not achieved commercial targets and are trading
behind plan. Protective provisions have, therefore, been taken against the
cost of certain holdings. The performance of fintech specialist Delio has been
impacted by slower than expected sales cycles and, although corrective
measures have been taken, the business continues to trade behind plan. As a
result of significant underperformance, the Manager elected not to provide
further support to Drovo and Turnkey, and the valuations of these holdings
have been written down in full.

 

Treasury Management

 

Your Company maintains a proactive approach to treasury management, where the
objective remains to optimise the income generated from cash held prior to
investment in VCT qualifying companies, whilst meeting the requirements of the
Nature of Income condition. This is a mandatory part of the VCT legislation,
which stipulates that not less than 70% of a VCT's income must be derived from
shares or securities. During 2023, the rise in interest rates required the
Board and the Manager to revise its approach and, following a whole of market
review, the composition of the treasury management portfolio was expanded to
include holdings in leading money market funds and open ended investment
companies (OEICs), alongside carefully selected London Stock Exchange listed
investment trusts. This approach enables your Company to maintain compliance
with the Nature of Income condition, whilst also generating a healthy new
stream of income from the portfolio of treasury management holdings and cash.

 

In line with the liquidity requirements of your Company, there were several
new investments and realisations within the Treasury Management portfolio,
details of which can be found in the Interim Report.

 

New Investments

 

During the reporting period, two new private companies were added to the
portfolio:

 

•     Alderley Lighthouse Labs is a provider of clinical diagnostic
testing services, specialising in the analysis of human samples such as blood,
urine and cells, with the objective of improving healthcare outcomes. The
business was initially established as a COVID-19 testing facility, as part of
the Government supported "Test and Trace" programme. As pandemic related
testing subsided, the business evolved into a laboratory based facility
providing blood science and molecular diagnostics to a wide range of clients.
The healthcare testing market continues to experience high growth and Alderley
is well placed to leverage its existing position, with scope to achieve
considerable scale. The funding from the Maven VCTs provides capital that will
enable the business to invest in product development, expand its current suite
of services and grow monthly revenues.

 

•     Zing is a specialist services provider operating in the
cloud-communications sector. It is a leading partner of global cloud
communication platform business Twilio, providing consultancy and managed
services. Zing was spun out from CRM provider ProspectSoft, a previous Maven
portfolio company, which was successfully exited in 2022. The funding from the
Maven VCTs will enable the business to benefit from the growth opportunities
in the Communications Platform as a Service (CPaaS) market. Since becoming an
independent business, Zing has made encouraging commercial progress and
strengthened its relationship with Twilio. The next stage of development is
focused on expanding into the US, developing a new AI proposition, and
enhancing the management team through new strategic hires.

 

The following investments were completed during the reporting period:

 

                                    Investments                             Date                    Sector                                                       £'000
                                    New unlisted
                                    Alderley Lighthouse Labs Limited(1)     April & May 2024        Pharmaceuticals,                                             249

                                                                                                    biotechnology & healthcare
                                    Zing TopCo Limited                      April & May 2024        Business services                                            185

                                    (trading as Zing)(1)
                                    Total new unlisted                                                                                                           434

                                    Follow-on unlisted
                                    Bud Systems Limited                     May 2024                Learning & development/ recruitment technology               116
                                    Delio Limited                           February 2024           Software & technology                                        125
                                    Draper & Dash Limited                   April & May 2024        Pharmaceuticals,                                             68

                                    (trading as RwHealth)(1)                                        biotechnology & healthcare
                                    Hublsoft Group Limited                  April 2024              Software & technology                                        56
                                    Liftango Group Limited                  March 2024              Software & technology                                        269
                                    mypura.com Group Limited                March 2024              Business services                                            193

                                    (trading as Pura)
                                    Relative Insight Limited                February 2024           Software & technology                                        66
                                    Shortbite Limited (trading as Fixtuur)  April 2024              Software & technology                                        37
                                    Snappy Shopper Limited                  April 2024              Software & technology                                        11
                                    Summize Limited                         June 2024               Software & technology                                        348
                                    Turnkey Group (UK) Holdings Limited(2)  January, February,      Software & technology                                        335

                                                                            April & June 2024
 XR Games Limited                                                           February 2024                                       Software & technology            48
 Zinc Digital Business Solutions Limited(1)                                 March & May 2024                                    Software & technology            239
 Total follow-on unlisted                                                                                                                                        1,911

 Total unlisted                                                                                                                                                  2,345

 New AIM quoted
 Cambridge Cognition Holdings PLC                                           June 2024                                           Pharmaceuticals,                 62

                                                                                                                                biotechnology & healthcare
 Total new AIM quoted                                                                                                                                            62

 Follow-on AIM quoted
 GENinCode PLC                                                              January 2024                                        Pharmaceuticals,                 160

                                                                                                                                biotechnology & healthcare
 Total follow-on AIM quoted                                                                                                                                      160

 Total AIM quoted                                                                                                                                                222

 Open ended investment companies(3)
 Royal Lond Short Term Money Market Fund (Class Y Income)                   April 2024                                          Money market fund                1,000
 Total open-ended investment companies                                                                                                                           1,000

 Money market funds(3)
 Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)          May 2024                                            Money market fund                1,000
 BlackRock Institutional Sterling Liquidity Fund (Core)                     March 2024                                          Money market fund                1,000
 Fidelity Institutional Liquidity Sterling Fund (Class F)                   March 2024                                          Money market fund                1,000
 Goldman Sachs Sterling Liquid Reserves (Institutional)                     January 2024                                        Money market fund                1,000
 Total money market funds                                                                                                                                        4,000

 Total investments                                                                                                                                               7,567

 

(1) Follow-on investment completed in two tranches.

(2) Follow-on investment completed in four tranches.

(3) Investments completed as part of the treasury management strategy.

 

At the period end, the portfolio comprised of 131 unlisted and quoted
investments, at a total cost of £73.4 million.

 

Realisations

 

In May 2024, the exit from graduate recruitment specialist GradTouch
completed. Your Company first invested in GradTouch in November 2019, backing
a team with a strategic plan to build a market leading position in the
graduate recruitment market. Throughout the period of ownership, the company
achieved steady organic growth alongside a series of self funded,
complementary acquisitions that helped to transform the business. During the
period under review, an offer to acquire the business was received from UK
private equity house Pelican Capital, and the exit generated a total return of
1.5x cost, inclusive of a small deferred consideration.

 

The table below gives details of the realisations completed during the
reporting period, including the exit from Quorum Cyber, which completed in
June 2024:

 

 Realisations                                                                                   Cost of shares                Sales proceeds                Gain/(loss) over 31 December 2023 value

                                                                    Year first   Complete/      disposed        Value at 31   £'000           Realised      £'000

                                                                    invested     partial exit   of              December                      gain/(loss)

                                                                                                £'000           2023                          £'000

                                                                                                                £'000
 Unlisted
 GradTouch Limited                                                  2019         Complete       200             292           303             103           11
 Project Falcon Topco Limited (trading as Quorum Cyber)             2021         Complete       419             419           1,278           859           859
 Other unlisted                                                                                 3               -             14              11            14
 Total unlisted                                                                                 622             711           1,595           973           884

 AIM quoted
 Faron Pharmaceuticals Oy                                           2019         Complete       71              83            48              (23)          (35)
 Oncimmune Holdings PLC                                             2021         Complete       100             14            13              (87)          (1)
 RUA Life Sciences PLC                                              2020         Complete       133             37            42              (91)          5
 Verici Dx PLC                                                      2020         Partial        65              31            26              (39)          (5)
 Total AIM quoted                                                                               369             165           129             (240)         (36)

 Money market funds(1)
 Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)  2023         Partial        1,000           1,000         1,000           -             -
 Goldman Sachs Sterling Liquid Reserves (Institutional)             2024         Complete       1,000           -             1,000           -             -
 HSBC Sterling Liquidity Fund (Class A)                             2023         Complete       1,000           1,000         1,000           -             -
 Total money market funds                                                                       3,000           2,000         3,000           -             -

 Open-ended investment companies(1)
 Royal London Short Term Money Market Fund (Class Y Income)         2023         Partial        986             983           974             (12)          (9)
 Total open-ended investment companies                                                          986             983           974             (12)          (9)

 Total realisations                                                                             4,977           3,859         5,698           721           839

 

(1) Realisations completed as part of the treasury management strategy.

 

During the year, one private company was struck off the Register of Companies,
resulting in a total realised loss of £249,000 (cost £249,000). This had no
effect on the NAV of the Company as a full provision had been taken against
the value of the holding in a previous period.

 

Material Developments Since the Period End

 

Since 30 June 2024, two new private company holdings have been added to the
portfolio:

 

·        Automated Analytics is the developer of a sales and marketing
platform that tracks the conversion of online "clicks" once they become
offline conversions, thereby enabling marketing and recruitment professionals
to optimise campaigns and budgets effectively. The platform uses advanced data
analytics alongside proprietary AI technology to analyse and process large
sets of data in real time, in order to allow clients to maximise the impact of
marketing spend and measure the true success of a digital campaign. Since
2021, the business has achieved a fivefold increase in ARR and built a strong
customer base that includes household names such as British Gas, Europcar, KFC
and Pizza Hut. The funding from the Maven VCTs is being used to accelerate
growth by expanding into new markets and making a number of strategic hires to
help further develop the technology platform.

 

·        Connected Data is a provider of a data enabled debt
management software solution, that is designed to improve recovery outcomes
for utility and financial services companies, which arise during unnotified
changes in tenancy and result in billions of pounds of unpaid energy and other
bills. The cloud-based platform uses propriety technology to help manage the
debt life cycle from pre-delinquency through to late stage collection,
offering a more cost effective solution to using a single credit bureau,
whilst also using multiple data sets to ensure fairer outcomes for customers.
The business is gaining commercial traction and has quickly established a blue
chip client base. The funding from the Maven VCTs will be used to further
develop the technology platform and invest in sales and marketing.

 

Principal and Emerging Risks and Uncertainties

 

The principal and emerging risks and uncertainties facing the Company were set
out in full in the Strategic Report contained within the 2023 Annual Report,
and are the risks associated with investment in small and medium sized
unlisted and AIM quoted companies which, by their nature, carry a higher level
of risk and are subject to lower liquidity than investments in larger quoted
companies. The valuation of investee companies may be affected by economic
conditions, the credit environment and other risks, including legislation,
regulation, adherence to VCT qualifying rules and the effectiveness of the
internal controls operated by the Company and the Manager. These risks and
procedures are reviewed regularly by the Risk Committee and reported to your
Board. The Board continues to monitor the criteria for VCT qualifying status
and can confirm that these are being adhered to.

 

Global conflict and political instability was added to the Risk Register as an
emerging risk during a previous period, as the Directors were not only aware
of the heightened cyber security risk but were mindful of the impact that any
change in the underlying economic conditions could have on the valuation of
investment companies. These included fluctuating interest rates, increased
fuel and energy costs, and the availability of bank finance, all of which
could be impacted during times of geopolitical uncertainty and volatile
markets. The Board and the Manager continue to monitor the impact of
geopolitical issues, and wider market conditions, on portfolio companies.

 

Share Buy-backs

 

In order to maintain an orderly market in the Company's shares, the Directors
have delegated authority to the Manager to enable the Company to buy back
shares in the secondary market for cancellation or to be held in treasury,
subject always to such transactions being in the best interests of
Shareholders.

 

It is intended that the Company will seek to buy back shares with a view to
maintaining a share price that is at a discount of approximately 5% to the
latest published NAV per share, subject to market conditions, availability
liquidity and the maintenance of the Company's VCT qualifying status. During
the period under review, 2,214,662 shares were bought back at a total cost of
£1.28 million.

 

Shareholders should note that neither the Company nor the Manager can execute
a transaction in the Company's shares and an instruction to buy or sell shares
on the secondary market must be directed through a stockbroker. If a
Shareholder wishes to discuss a transaction, they or their broker can contact
the Company's stockbroker, Shore Capital Stockbrokers on 020 7647 8132. Such
transactions are, however, prohibited whilst the Company is in a closed
period, which is the time from the end of a reporting period until the
announcement of the relevant results, or the release of an unaudited NAV.
Additionally, a closed period may be introduced if the Directors and Manager
are in possession of price sensitive information.

 

VCT Regulatory Update

 

During the period under review, there were no further amendments to the rules
governing VCTs, and your Company remains fully compliant with the complex
conditions and requirements as set out by HMRC.

 

Although the precise details of the new Government's economic and fiscal
policy are currently unknown, the Manager has, through the VCT Association
(VCTA), been actively involved in positive cross party dialogue to promote and
reinforce the important role that VCTs play in supporting some of Britain's
brightest and most entrepreneurial smaller companies, whilst also assisting in
job creation across the regions. It is pleasing to note that, on 3 September
2024, HM Treasury approved the regulations required to lift the "sunset
clause" and extend VCT and EIS schemes until 2035. This provides greater
certainty to SME's seeking growth capital that VCTs will remain a central
component of the UK's funding infrastructure.

 

Valuation Methodology

 

Consistent with industry best practice, the Board and the Manager continue to
apply the International Private Equity and Venture Capital Valuation (IPEV)
Guidelines as the central methodology for all private company valuations. The
IPEV Guidelines are the prevailing framework for fair value assessment in the
private equity and venture capital industry. The Directors and the Manager
continue to follow industry guidelines and adhere to the IPEV Guidelines in
all private company valuations. In accordance with normal market practice,
investments quoted on AIM, or another recognised stock exchange, are valued at
their closing bid price at the period end.

 

Environmental, Social and Governance (ESG)

 

Whilst the Manager continues to enhance its ESG framework, it should be noted
that your Company's investment policy does not incorporate specific ESG aims,
and portfolio companies are not required to meet any specific targets.
However, as a growth investor, Maven is well positioned to help each company
establish robust ESG practices at an early stage of its corporate development,
ensuring that they are ingrained in the culture as the business grows. The
Manager believes that strong core ESG credentials help support responsible
growth and encourage positive social and environmental behaviours.

 

Your Company has multiple investments in companies with strong ESG credentials
that are achieving growth in expanding markets. The Manager is committed to
maintaining a responsible approach to new and existing investments, and has
developed a framework for promoting ESG credentials by actively engaging with
portfolio companies, taking into consideration material issues at the point of
investment as well as monitoring progress annually. All potential investee
companies are required to complete an ESG assessment that covers ten key areas
and provides a comprehensive pre-investment evaluation of the business, with a
focus on governance, board composition and culture, alongside environmental
and social considerations.

 

The Manager continues to be an active signatory to the UN Principles for
Responsible Investment (UNPRI) and Investing in Women Code. Alongside these
external initiatives, Maven has developed diversity initiatives, including
launching a Female Founder Funding programme that aims to offer mentorship and
collaboration opportunities to female entrepreneurs across the UK.

 

Outlook

 

Whilst M&A activity in 2023 was stifled by market uncertainty and
geopolitical concerns, there has been a strong recovery in the year to date
and it is pleasing to note the completion of several high value exits. The
companies in the unlisted portfolio continue to attract regular acquisition
interest from a range of UK and international buyers, and completing further
profitable exits to help support your Company's ongoing dividend programme
remains a key objective for the second half of the year.

 

Fraser Gray

Chairman

 

18 September 2024

 

 

Summary Of Investment Changes

 

Six Months Ended 30 June 2024

 

                        Valuation             Net investment/ (disinvestment)  Appreciation/ (depreciation)  Valuation

                        31 December 2023      £'000                            £'000                         30 June 2024
                        £'000      %                                           £'000                                  %
 Unlisted investments
 Equities               48,291     57.5       652                              4,325                         53,268   59.8
 Loan stock             13,382     15.9       98                               (5)                           13,485   15.1
                        61,673     73.4       750                              4,330                         66,753   74.9

 AIM Investments(1)
 Equities               3,894      4.6        93                               (817)                         3,170    3.6

 Other investments(2)
 OEICs                  2,035      2.4        26                               (25)                          2,036    2.3
 MMFs                   4,000      4.8        1,000                            -                             5,000    5.5
 Investment trusts      5,635      6.7        -                                142                           5,777    6.5
 Total investments      77,237     91.9       1,869                            3,630                         82,736   92.8

 Other net assets       6,680      8.1        (266)                            -                             6,414    7.2
 Net assets             83,917     100.0      1,603                            3,630                         89,150   100.0

 

(1)   Shares traded on the Alternative Investment Market (AIM) and the Main
Market of the London Stock Exchange.

(2)   These holdings represent the treasury management portfolio, which has
been constructed from a range of carefully selected, permitted non-qualifying
holdings in investment trusts, open-ended investment companies (OEICs) and
money market funds (MMFs).

 

 

Investment Portfolio Summary

 

As At 30 June 2024

 

 Investment                                                                   Valuation  Cost     % of     % of     % of equity held by other clients(1)

                                                                              £'000      £'000    total    equity

                                                                                                  assets   held
 Unlisted
 Horizon Ceremonies Limited                                                   4,769      2,463    5.3      12.9     39.7

 (trading as Horizon Cremation)
 BioAscent Discovery Limited                                                  4,713      1,532    5.2      26.1     13.9
 MirrorWeb Limited                                                            4,179      990      4.7      8.5      41.4
 Bright Network (UK) Limited                                                  3,218      1,706    3.6      9.8      29.3
 Rockar 2016 Limited (trading as Rockar)                                      3,110      1,766    3.5      6.2      13.2
 WaterBear Education Limited                                                  2,905      987      3.3      19.9     18.9
 QikServe Limited                                                             2,038      1,674    2.3      7.6      8.2
 HCS Control Systems Group Limited                                            1,942      1,201    2.2      10.7     25.8
 Ensco 969 Limited (trading as DPP)                                           1,857      1,532    2.1      7.4      27.1
 CB Technology Group Limited                                                  1,813      1,097    2.0      18.6     56.4
 Novatus Global Limited                                                       1,649      562      1.8      3.5      15.2
 NorthRow Limited                                                             1,482      1,699    1.7      12.3     20.5
 Vodat Communications Group (VCG) Holding Limited                             1,427      1,240    1.6      8.4      23.5
 Zinc Digital Business Solutions Limited                                      1,301      867      1.5      15.6     28.0
 Summize Limited                                                              1,275      796      1.4      4.0      30.3
 Relative Insight Limited                                                     1,201      1,201    1.3      5.7      25.6
 Filtered Technologies Limited                                                1,184      1,100    1.3      9.7      15.8
 Hublsoft Group Limited                                                       1,138      922      1.3      7.3      16.4
 ebb3 Limited                                                                 1,125      1,307    1.3      31.4     47.5
 Martel Instruments Holding Limited                                           1,038      701      1.2      14.7     29.6
 Liftango Group Limited                                                       1,016      1,016    1.1      6.3      34.4
 Whiterock Group Limited                                                      1,014      1,014    1.1      11.2     26.7
 RevLifter Limited                                                            1,000      1,000    1.1      10.2     16.4
 2degrees Limited                                                             970        698      1.1      2.5      8.6

 (trading as Manufacture 2030)
 Bud Systems Limited                                                          953        762      1.1      4.1      13.5
 CYSIAM Limited                                                               944        448      1.1      5.8      22.0
 Nano Interactive Group Limited                                               929        625      1.0      3.7      11.2
 Boomerang Commerce Inc                                                       873        1,164    1.0      0.2      0.3

 (trading as CommerceIQ)(2)
 DiffusionData Limited                                                        853        625      1.0      3.1      14.9
 Precursive Limited                                                           750        750      0.8      5.5      29.0
 Flow UK Holdings Limited                                                     735        1,047    0.8      12.7     22.3
 Cat Tech International Limited                                               717        1,115    0.8      8.4      21.6
 ORCHA Health Limited                                                         709        709      0.8      2.8      5.0
 Growth Capital Ventures Limited                                              650        639      0.7      11.5     36.0
 Maven Capital (Marlow) Limited                                               650        650      0.7      -        100.0
 Delio Limited                                                                644        1,294    0.7      6.0      11.6
 XR Games Limited                                                             639        299      0.7      1.7      21.5
 Draper & Dash Limited                                                        621        621      0.7      6.0      43.0

 (trading as RwHealth)
 mypura.com Group Limited                                                     608        409      0.7      1.6      21.2

 (trading as Pura)
 CODILINK UK Limited (trading as Coniq)                                       600        400      0.7      1.1      3.8
 Metrion Biosciences Limited                                                  597        597      0.7      4.3      13.9
 Plyable Limited                                                              597        597      0.7      6.8      19.8
 Sensoteq Limited                                                             597        597      0.7      5.6      18.0
 Enpal Limited                                                                581        581      0.7      3.2      18.4

 (trading as Guru Systems)
 The Algorithm People Limited                                                 558        420      0.6      6.1      10.2

 (trading as Optimize)
 TC Communications Holdings Limited                                           551        958      0.6      12.6     22.7
 iAM Compliant Limited                                                        492        298      0.6      3.9      45.3
 Horizon Technologies Consultants Limited                                     466        448      0.5      3.1      14.1
 Biorelate Limited                                                            419        348      0.5      2.0      23.7
 Laverock Therapeutics Limited                                                398        398      0.4      1.9      7.5
 Shortbite Limited                                                            347        798      0.4      10.0     60.8

 (trading as Fixtuur)
 HiveHR Limited                                                               346        346      0.4      4.4      40.2
 Snappy Shopper Limited                                                       309        309      0.3      0.4      1.3
 AMufacture Limited                                                           261        261      0.3      4.8      15.2
 Alderley Lighthouse Labs Limited                                             249        249      0.3      6.7      46.9
 Zing TopCo Limited (trading as Zing)                                         185        185      0.2      4.9      42.8
 McKenzie Intelligence Services Limited                                       159        159      0.2      1.6      4.8
 ISN Solutions Group Limited                                                  143        467      0.2      7.8      47.2
 Reed Thermoformed Packaging Limited (trading as iPac Packaging Innovations)  140        100      0.2      0.5      11.8
 Rico Developments Limited                                                    100        200      0.1      1.6      8.3

 (trading as Adimo)
 Other unlisted investments                                                   19         3,699    -
 Total unlisted                                                               66,753     52,643   74.9

 AIM quoted(3)
 GENinCode PLC                                                                454        760      0.6      6.4      15.3
 MaxCyte Inc                                                                  383        207      0.5      0.1      0.1
 Kanabo Group PLC(4)                                                          330        2,986    0.4      3.7      6.3
 Diaceutics PLC                                                               260        161      0.3      0.3      0.3
 Intelligent Ultrasound Group PLC                                             248        400      0.3      1.2      0.8
 Oxford Metrics PLC                                                           231        80       0.3      0.2      -
 Verici Dx PLC                                                                112        373      0.1      1.1      0.3
 Eden Research PLC                                                            111        160      0.1      0.5      1.0
 KRM22 PLC                                                                    110        220      0.1      1.2      -
 SkinBioTherapeutics PLC                                                      110        208      0.1      0.7      -
 One Media IP Group PLC                                                       106        186      0.1      1.2      -
 C4X Discovery Holdings PLC                                                   96         137      0.1      0.4      0.5
 Creo Medical Group PLC                                                       89         497      0.1      0.1      -
 TPXimpact Holdings PLC                                                       66         107      0.1      0.2      -
 Pulsar Group PLC                                                             61         35       0.1      0.1      0.4

 (formerly Access Intelligence PLC)
 AFC Energy PLC                                                               59         57       0.1      -        -
 Cambridge Cognition Holdings PLC                                             59         62       0.1      0.4      1.1
 Avacta Group PLC                                                             54         16       0.1      -        -
 Vianet Group PLC                                                             43         49       -        0.1      1.3
 Feedback PLC                                                                 42         121      -        0.4      1.2
 Destiny Pharma PLC                                                           27         206      -        0.3      0.3
 Crossword Cybersecurity PLC                                                  24         122      -        0.4      1.7
 Spectral AI Inc                                                              22         99       -        -        -
 Angle PLC                                                                    19         82       -        0.1      -
 Hardide PLC                                                                  15         122      -        0.3      0.2
 ReNeuron Group PLC                                                           13         277      -        0.7      1.4
 Other quoted investments                                                     26         1,071    -
 Total AIM quoted                                                             3,170      8,801    3.6

 Private equity investment trusts(5)
 HgCapital Trust PLC                                                          1,012      531      1.1      -        0.1
 Patria Private Equity Trust PLC                                              516        367      0.6      0.1      0.2

 (formerly abrdn Private Equity Opportunities Trust PLC)
 ICG Enterprise Trust PLC                                                     483        381      0.5      0.1      0.1
 Partners Group Private Equity Limited (formerly Princess Private Equity      379        336      0.4      0.1      0.1
 Holding Limited)
 Apax Global Alpha Limited                                                    370        344      0.4      -        0.1
 CT Private Equity Trust PLC                                                  362        293      0.4      0.1      0.3
 NB Private Equity Partners Limited                                           360        371      0.4      0.1      0.2
 HarbourVest Global Private Equity Limited                                    268        153      0.3      -        -
 Pantheon International PLC                                                   144        99       0.2      -        0.1
 Total private equity investment trusts                                       3,894      2,875    4.3

 Infrastructure investment trusts(5)
 3i Infrastructure PLC                                                        256        260      0.3      -        -
 BBGI Global Infrastructure SA                                                248        280      0.3      -        0.1
 International Public Partnerships Limited                                    238        270      0.3      -        -
 Pantheon Infrastructure PLC                                                  225        250      0.3      0.1      0.2
 JLEN Environmental Assets Group Limited                                      187        260      0.2      -        0.1
 Total infrastructure investment trusts                                       1,154      1,320    1.4
 Fixed income investment trusts(5)
 TwentyFour Income Fund Limited                                               175        195      0.2      0.1      -
 Alcentra European Floating Rate Income Fund Limited                          9          11       -        -        -
 Total fixed income investment trust                                          184        206      0.2

 Global equity investment trusts(5)
 Alliance Trust PLC                                                           181        149      0.2      -        -
 JPMorgan Global Growth & Income PLC                                          157        25       0.2      -        -
 Total fixed income investment trusts                                         338        274      0.4

 Real estate investment trusts(5)
 Impact Healthcare REIT PLC                                                   207        235      0.2      0.1      0.1
 Total real estate investment trusts                                          207        235      0.2
 Open-ended investment companies(5)
 Royal London Short Term Fixed Income Fund (Class Y Income)                   1,028      1,020    1.2      0.1      0.2
 Royal London Short Term Monet Market Fund (Class Y Income)                   1,008      1,026    1.1      -        -
 Total open-ended investment companies                                        2,036      2,046    2.3
 Money market funds(5)
 Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)            1,000      1,000    1.1      -        -
 Aviva Investors Sterling Government Liquidity Fund                           1,000      1,000    1.1      -        -
 BlackRock Institutional Sterling Government Liquidity Fund (Core Dis)        1,000      1,000    1.1      -        -
 BlackRock Institutional Sterling Liquidity Fund (Core)                       1,000      1,000    1.1      -        -
 Fidelity Institutional Liquidity Sterling Fund (Class F)                     1,000      1,000    1.1      0.1      0.2
 Total money market funds                                                     5,000      5,000    5.5

 Total investments                                                            82,736     73,400   92.8

 

(1) Other clients of Maven Capital Partners UK LLP.

(2) This holding reflects the retained minority interest following the sale of
e.fundamentals (Group) Limited to CommerceIQ in July 2022.

(3) Investments are quoted on AIM with the exception of Kanabo Group PLC,
which is listed on the Main Market of the London Stock Exchange.

(4) The holding in this investment resulted from the sale of The GP Service
(UK) Limited, which completed in February 2022. The unlisted shares in Kanabo
GP Limited were, in accordance with the terms of the original transaction,
exchanged for shares in Kanabo Group PLC, which is listed on the Main Market
of the London Stock Exchange.

(5) Treasury management portfolio.

 

Shaded line indicates that the investment was completed pre November 2015.

 

 

Income Statement

 

For the Six Months Ended 30 June 2024

 

                                             Six months ended to              Six months ended to              Year ended

                                             30 June 2024 (unaudited)         30 June 2023 (unaudited)         31 December 2023 (audited)
                                             £'000      £'000      £'000      £'000      £'000      £'000      £'000       £'000       £'000
 Gain/(loss) on investments                  -          3,630      3,630      -          (1,689)    (1,689)    -           (2,989)     (2,989)
 Income from investments                     792        -          792        561        -          561        1,262       -           1,262
 Other income                                87         -          87         176        -          176        299         -           299
 Investment management fees                  (212)      (850)      (1,062)    (225)      (898)      (1,123)    (449)       (1,797)     (2,246)
 Other expenses                              (222)      -          (222)      (286)      -          (286)      (633)       -           (633)
 Net return on ordinary                      445        2,780      3,225      226        (2,587)    (2,361)    479         (4,786)     (4,307)

 activities before taxation
 Tax on ordinary activities                  -          -          -          -          -          -          -           -           -
 Return attributable to Equity Shareholders  445        2,780      3,225      226        (2,587)    (2,361)    479         (4,786)     (4,307)

 Earnings per share (pence)                  0.32       1.97       2.29       0.17       (1.92)     (1.75)     0.35        (3.52)      (3.17)

 

All gains and losses are recognised in the Income Statement.

 

The total column of this statement is the Profit & Loss Account of the
Company. The revenue and capital return columns are prepared in accordance
with the AIC SORP. All items in the above statement derive from continuing
operations. No operations were acquired or discontinued during the period.

 

There are no potentially dilutive capital instruments in issue and, therefore,
no diluted earnings per share figures are relevant. The basic and diluted
earnings per share are, therefore, identical.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Statement of Changes in Equity

 

For the six months ended 30 June 2024

 

Six months ended 30 June 2024 (unaudited)

                                        Non-distributable reserves                                        Distributable reserves

                                        Share capital  Share     Capital redemption  Capital      Capital           Special         Revenue reserve  Total

                                        £'000          premium   reserve             reserve      reserve           distributable   £'000            £'000

                                                       account   £'000               unrealised   realised          reserve

                                                       £'000                         £'000        £'000             £'000
 At 31 December 2023                    13,596         43,470    1,196               9,150        4,174             10,883          1,448            83,917
 Net return                             -              -         -                   2,739        891               (850)           445              3,225
 Dividends paid                         -              -         -                   -            -                 (2,295)         (215)            (2,510)
 Repurchase and cancellation of shares  (221)          -         221                 -            -                 (1,285)         -                (1,285)
 Net proceeds of share issue            916            4,657     -                   -            -                 -               -                5,573
 Net proceeds of DIS issue*             42             188       -                   -            -                 -               -                230
 At 30 June 2024                        14,333         48,315    1,417               11,889       5,065             6,453           1,678            89,150

 

Six months ended 30 June 2023 (unaudited)

                                        Non-distributable reserves                                Distributable reserves
                                        Share capital  Share     Capital redemption  Capital      Capital    Special         Revenue reserve  Total

                                        £'000          premium   reserve             reserve      reserve    distributable   £'000            £'000

                                                       account   £'000               unrealised   realised   reserve

                                                       £'000                         £'000        £'000      £'000
 At 31 December 2022                    12,977         37,443    762                 12,100       4,213      19,975          1,174            88,644
 Net return                             -              -         -                   (1,893)      204        (898)           226              (2,361)
 Dividends paid                         -              -         -                   -            -          (2,328)         (68)             (2,396)
 Repurchase and cancellation of shares  (177)          -         177                 -            -          (1,145)         -                (1,145)
 Net proceeds of share issue            978            5,729     -                   -            -          -               -                6,707
 Net proceeds of DIS issue*             37             208       -                   -            -          -               -                245
 At 30 June 2023                        13,815         43,380    939                 10,207       4,417      15,604          1,332            89,694

 

Year ended 31 December 2023 (audited)

                                        Non-distributable reserves                                Distributable reserves
                                        Share capital  Share     Capital redemption  Capital      Capital    Special         Revenue reserve  Total

                                        £'000          premium   reserve             reserve      reserve    distributable   £'000            £'000

                                                       account   £'000               unrealised   realised   reserve

                                                       £'000                         £'000        £'000      £'000
 At 31 December 2022                    12,977         37,443    762                 12,100       4,213      19,975          1,174            88,644
 Net return                             -              -         -                   (2,950)      (39)       (1,797)         479              (4,307)
 Dividends paid                         -              -         -                   -            -          (4,580)         (205)            (4,785)
 Repurchase and cancellation of shares  (434)          -         434                 -            -          (2,715)         -                (2,715)
 Net proceeds of share issue            978            5,615     -                   -            -          -               -                6,593
 Net proceeds of DIS issue*             75             412       -                   -            -          -               -                487
 At 31 December 2023                    13,596         43,470    1,196               9,150        4,174      10,883          1,448            83,917

 

*DIS represents the Dividend Investment Scheme as detailed in the Interim
Review.

 

The capital reserve unrealised is generally non-distributable other than the
part of the reserve relating to gains/(losses) attributable to readily
realisable quoted investments which are distributable.

 

Where all, or an element, of the proceeds of sales have not been received in
cash or cash equivalent, and are not readily convertible to cash, they do not
qualify as realised gains for the purposes of distributable reserves
calculations and, therefore, do not form part of distributable reserves.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Balance Sheet

 

As at 30 June 2024

 

                                                   30 June 2024  30 June 2023  31 December 2023

                                                   (unaudited)   (unaudited)   (audited)

                                                   £'000         £'000         £'000
 Fixed assets
 Investments at fair value through profit or loss  82,736        74,919        77,237

 Current assets
 Debtors                                           1,486         1,542         1,506
 Cash                                              5,243         13,419        5,458
                                                   6,729         14,961        6,964
 Creditors
 Amounts falling due within one year               (315)         (186)         (284)
 Net current assets                                6,414         14,775        6,680
 Net assets                                        89,150        89,694        83,917

 Capital and reserves
 Called up share capital                           14,333        13,815        13,596
 Share premium account                             48,315        43,380        43,470
 Capital redemption reserve                        1,417         939           1,196
 Capital reserve - unrealised                      11,889        10,207        9,150
 Capital reserve - realised                        5,065         4,417         4,174
 Special distributable reserve                     6,453         15,604        10,883
 Revenue reserve                                   1,678         1,332         1,448
 Net assets attributable to Ordinary Shareholders  89,150        89,694        83,917
 Net asset value per Ordinary Share (pence)        62.19         64.92         61.71

 

The Financial Statements of Maven Income and Growth VCT 4 PLC, registered
number SC272568, were approved and authorised for issue by the Board of
Directors and were signed on its behalf by:

 

 

Fraser Gray

Director

 

18 September 2024

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Cash Flow Statement

 

For the Six Months Ended 30 June 2024

 

                                           Six months ended  Six months ended 30 June 2023  Year ended

                                           30 June 2024      (unaudited)                    31 December 2023

                                           (unaudited)       £'000                          (audited)

                                           £'000                                            £'000
 Net cash flows from operating activities  (612)             (662)                          (1,308)

 Cash flows from investing activities
 Purchase of investments                   (7,567)           (11,150)                       (19,583)
 Sale of investments                       5,861             1,468                          6,320
 Net cash flows from investing activities  (1,706)           (9,682)                        (13,263)

 Cash flows from financing activities
 Equity dividends paid                     (2,510)           (2,396)                        (4,785)
 Net proceeds of DIS issue                 234               245                            6,707
 Issue of Ordinary Shares                  5,664             6,707                          470
 Repurchase of Ordinary Shares             (1,285)           (1,145)                        (2,715)
 Net cash flows from financing activities  2,103             3,411                          (323)

 Net decrease in cash                      (215)             (6,933)                        (14,894)

 Cash as at beginning of period            5,458             20,352                         20,352
 Cash at end of period                     5,243             13,419                         5,458

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Notes to the Financial Statements

 

1.  Accounting Policies

 

The financial information for the six months ended 30 June 2024 and the six
months ended 30 June 2023 comprises non-statutory accounts within the meaning
of S435 of the Companies Act 2006. The financial information contained in this
report has been prepared on the basis of the accounting policies set out in
the Annual Report and Financial Statements for the year ended 31 December
2023, which have been filed at Companies House and contained an Auditor's
Report that was not qualified and did not contain a statement under S498(2) or
S498(3) of the Companies Act 2006.

 

2.  Reserves

 

Share premium account

 

The share premium account represents the premium above nominal value received
by the Company on issuing shares net of issue costs, including £67,880
current period trail commission (cumulative £181,574). This reserve is
non-distributable.

 

Capital redemption reserve

 

The nominal value of shares repurchased and cancelled is represented in the
capital redemption reserve. This reserve is non-distributable.

 

Capital reserve - unrealised

 

Increases and decreases in the fair value of investments are recognised in the
Income Statement and are then transferred to the capital reserve unrealised
account. This reserve is generally non-distributable, other than the part of
the reserve relating to gains/ (losses) attributable to readily realisable
quoted investments that are distributable.

 

Capital reserve - realised

 

Gains or losses on investments realised in the year that have been recognised
in the Income Statement are transferred to the capital reserve realised
account on disposal. Furthermore, any prior unrealised gains or losses on such
investments are transferred from the capital reserve unrealised account to the
capital reserve realised account on

disposal. This reserve is distributable.

 

Special distributable reserve

 

The total cost to the Company of the repurchase and cancellation of shares is
represented in the special distributable reserve account. The special
distributable reserve also represents capital dividends, capital investment
management fees and the tax effect of capital items. This reserve is
distributable.

 

Revenue reserve

 

The revenue reserve represents accumulated profits retained by the Company
that have not been distributed to Shareholders. This reserve is distributable.

 

3.  Return per Ordinary Share

 

                                                                  Six months ended 30 June 2024
 The returns per share have been based on the following figures:

 Weighted average number of Ordinary Shares                       141,047,313

 Revenue return                                                   £445,000

 Capital return                                                   £2,780,000
 Total return                                                     £3,225,000

 

Directors' Responsibility Statement

 

Each Director believes that, to the best of their knowledge:

 

·     the Financial Statements for the six months ended 30 June 2024 have
been prepared in accordance with FRS 102, the Financial Reporting Standard
applicable in the UK and the Republic of Ireland;

 

·     the Interim Management Report includes a fair review of the
information required by DTR 4.2.7R in relation to the indication of important
events during the first six months, and of the principal and emerging risks
and uncertainties facing the Company during the second six months, of the year
ending 31 December 2024; and

 

·     the Interim Management Report includes adequate disclosure of the
information required by DTR 4.2.8R in relation to material related party
transactions and any changes therein.

 

Other information

 

The NAV per Ordinary Share has been calculated using the number of Ordinary
Shares in issue at 30 June 2024, which was 143,341,152. A Summary of
Investment Changes for the six months under review and an Investment Portfolio
Summary as at 30 June 2024 are included above. A full copy of the Interim
Report and Financial Statements will be printed and issued to Shareholders in
due course. Copies of this announcement will be available to the public at the
registered office of the Company at Kintyre House, 205 West George Street,
Glasgow G2 2LW; at the office of the Manager, Maven Capital Partners UK LLP,
Saddlers House, 44 Gutter Lane, London, EC2V 6BR; and, in due course, on the
Company's webpage at mavencp.com/migvct4 (http://www.mavencp.com/migvct4) .

 

Neither the content of the Company's webpages nor the contents of any website
accessible from hyperlinks on the Company's website (or any other website) is
incorporated into, or forms part of, this announcement.

 

 

On behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

18 September 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR EAENPFEPLEFA

Recent news on Maven Income and Growth VCT 4

See all news